• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

SELLAS Life Sciences Group, Inc. - Common Stock (NQ:SLS)

3.770 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 31,973
Open 3.770
Bid (Size) 4.110 (900)
Ask (Size) 4.180 (400)
Prev. Close 3.770
Today's Range 3.770 - 3.770
52wk Range 0.8505 - 3.990
Shares Outstanding 15,873,941
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Why Is SLS Stock Drawing Significant Investor Attention Today? ↗
December 31, 2025
Maxim analyst Jason McCarthy noted that because the trial is event-driven rather than time-driven, slower accrual of deaths can simply reflect longer patient survival, a positive sign for the... 
Via Stocktwits
Topics Death
News headline image
Biopharma’s Year-End Rollercoaster: Mereo Plummets 90% as BioMarin Seals $4.8 Billion Amicus Deal
December 29, 2025
The biopharmaceutical sector witnessed a dramatic surge in volatility today, December 29, 2025, as the industry careened toward the end of its strongest year in two decades. In a day defined by extreme... 
Via MarketMinute
Topics ETFs Intellectual Property

Performance

YTD
N/A
N/A
1 Month
+171.2%
+171.2%
3 Month
+120.5%
+120.5%
6 Month
+73.7%
+73.7%
1 Year
+252.3%
+252.3%

More News

Read More
News headline image
SELLAS Life Sciences Group Stock Soars As It Nears Final Analysis In Cancer Study ↗
December 29, 2025
Via Stocktwits
Topics Death
Why Is SELLAS Life Sciences Stock Falling Today? ↗
October 27, 2025
Via Stocktwits
News headline image
SLS Stock Has Risen 78% In A Month — What’s The Retail Buzz About? ↗
December 24, 2025
Via Stocktwits
News headline image
Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge
December 24, 2025
From Equity Insider
Via GlobeNewswire
News headline image
These stocks are gapping in today's session ↗
December 23, 2025
Via Chartmill
News headline image
SELLAS Life Sciences Stock Has Doubled This Year – Here’s Why Retail Investors Are Bullish ↗
December 17, 2025
Via Stocktwits
Topics Death
News headline image
SELLAS Life Sciences Draws Retail Buzz On SLS009 Trial Momentum – Stock Soars In Pre-Market ↗
December 08, 2025
Via Stocktwits
Topics Artificial Intelligence
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
November 11, 2025
Via Benzinga
News headline image
Papa John's Is Not First: Here Are 3 Other Stocks Rocked By Market-Moving Fake News ↗
November 11, 2025
Via Benzinga
News headline image
These stocks are moving in today's after hours session ↗
October 20, 2025
Via Chartmill
News headline image
Sellas Life Sciences Stock Jumps Over 7% Premarket: Buzz Builds Ahead Of Weekend Cancer Drug Presentation In Berlin ↗
October 16, 2025
Via Stocktwits
News headline image
SELLAS Life Sciences Stock Rises On Strong Preclinical Data For Investigational Cancer Treatment ↗
October 13, 2025
Via Stocktwits
News headline image
Sellas Life Sciences Stock In Spotlight After Institutional Investor Exercises Existing Warrants ↗
September 11, 2025
Via Stocktwits
News headline image
SELLAS Life Sciences Group Inc (NASDAQ:SLS) Reports Q2 2025 Earnings: Narrower Loss and Clinical Progress Amid Revenue Challenges ↗
August 12, 2025
Via Chartmill
News headline image
Wall Street Eyes Breakout Cancer Therapies Amid Soaring Drug Prices
June 24, 2025
Via FinancialNewsMedia
News headline image
Thursday's after hours session: top gainers and losers ↗
May 22, 2025
Via Chartmill
News headline image
Top movers in Tuesday's after hours session ↗
May 13, 2025
Via Chartmill
News headline image
Wondering what's happening in today's after-hours session? ↗
April 08, 2025
Via Chartmill
News headline image
What's going on in today's after hours session ↗
January 30, 2025
Via Chartmill
News headline image
These stocks are moving in today's session ↗
January 27, 2025
Via Chartmill
News headline image
8 Health Care Stocks Whale Activity In Today's Session ↗
January 20, 2025
Via Benzinga
News headline image
SLS Stock Earnings: SELLAS Life Sciences Gr Beats EPS for Q2 2024 ↗
August 13, 2024
Via InvestorPlace
News headline image
Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
June 17, 2024
Via Benzinga

Frequently Asked Questions

Is SELLAS Life Sciences Group, Inc. - Common Stock publicly traded?
Yes, SELLAS Life Sciences Group, Inc. - Common Stock is publicly traded.
What exchange does SELLAS Life Sciences Group, Inc. - Common Stock trade on?
SELLAS Life Sciences Group, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for SELLAS Life Sciences Group, Inc. - Common Stock?
The ticker symbol for SELLAS Life Sciences Group, Inc. - Common Stock is SLS on the Nasdaq Stock Market
What is the current price of SELLAS Life Sciences Group, Inc. - Common Stock?
The current price of SELLAS Life Sciences Group, Inc. - Common Stock is 3.770
When was SELLAS Life Sciences Group, Inc. - Common Stock last traded?
The last trade of SELLAS Life Sciences Group, Inc. - Common Stock was at 12/31/25 04:00 PM ET
What is the market capitalization of SELLAS Life Sciences Group, Inc. - Common Stock?
The market capitalization of SELLAS Life Sciences Group, Inc. - Common Stock is 59.84M
How many shares of SELLAS Life Sciences Group, Inc. - Common Stock are outstanding?
SELLAS Life Sciences Group, Inc. - Common Stock has 60M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap